PCV117 COST-UTILITY OF BOSENTAN IN THE FIRST-LINE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN FINLAND-A DISCRETE EVENT SIMULATION MODELLING

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74644-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)74644-1/fulltext
Title : PCV117 COST-UTILITY OF BOSENTAN IN THE FIRST-LINE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN FINLAND-A DISCRETE EVENT SIMULATION MODELLING
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74644-1&doi=10.1016/S1098-3015(10)74644-1
First page :
Section Title :
Open access? : No
Section Order : 573
Categories :
Tags :
Regions :
ViH Article Tags :